RI Terms and news10 Mar 2026 07:58
So, the RI is fully underwritten and the funds will be received come what may, so no issues there.
What we really want now is some positive clinical news, which will increase the SP. This in turn will increase the value of the rights and the nil paid, due to the short term leverage of being granted the right to subscribe for extra shares at a slightly discounted SP. It becomes a geared play in the short term, and the funding runway is extended up to 18 months or so as well.
Hopefully upwards from here!